| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved | ligand |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | ligand |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.15 | approved | ligand |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | ligand |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | ligand,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator,positive modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.22 | approved | positive allosteric modulator |
| oxazepam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.22 | approved | positive allosteric modulator,positive modulator |
| oxazepam | translocator protein | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Alcohol consumption[MeSHID:D000428] Anxiety Disorders[MeSHID:D001008] Withdrawal Symptoms[MeSHID:D013375] Anxiety[MeSHID:D001007] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved | unknown |
| click here to return to the previous page | ||||||||